The goal of this proposal is to establish an Experimental Cancer Imaging Research Program (ECIRP) at The University of Texas M. D. Anderson Cancer Center. The program will serve as a local-regional resource for small animal imaging. M. D. Anderson is a charter NCI designated Comprehensive Cancer Center. Our mission focus is the elimination of cancer as a significant health issue. Research at M. D. Anderson is broad and deep. We have ten active SPORE grants, 13 program project grants and a P30 Cancer Center Support grant that all promote multidisciplinary research. M. D. Anderson has invested significantly to develop the infrastructure, including state-of-the-art instrumentation, and departmental resources necessary to include experimental animal imaging in ongoing cancer research and to carry out innovative research in biomedical imaging. This commitment is exemplified by the creation of a Small Animal Imaging Facility (SAIF) shared research resource and establishing a Center for Advanced Biomedical Imaging Research (CABIR). The CABIR will be housed in a dedicated building with a scheduled occupancy in summer 2008. Imaging modalities will include magnetic resonance (MRI), nuclear (planar, SPECT and PET), x-ray computed tomography (CT), optical (fluorescence and bioluminescence) and ultrasound. Five research cores will be established to support base grant users: Contrast Agents, Instrumentation, Genetic &Cellular Tracers, Radiotracers, and Image Processing and Visualization. These cores will support ongoing research (base grants) in lung cancer, drug development, vascular targeted therapies, targeted optical imaging and reporter genes for imaging in the first year. A process for identifying developing projects will be established to promote new base grants in subsequent years.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Resource-Related Research Projects--Cooperative Agreements (U24)
Project #
5U24CA126577-05
Application #
8050127
Study Section
Special Emphasis Panel (ZCA1-GRB-S (J1))
Program Officer
Zhang, Huiming
Project Start
2007-03-26
Project End
2013-02-28
Budget Start
2011-03-29
Budget End
2013-02-28
Support Year
5
Fiscal Year
2011
Total Cost
$439,877
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Radiation-Diagnostic/Oncology
Type
Other Domestic Higher Education
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Mendt, Mayela; Kamerkar, Sushrut; Sugimoto, Hikaru et al. (2018) Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight 3:
Kamerkar, Sushrut; LeBleu, Valerie S; Sugimoto, Hikaru et al. (2017) Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature 546:498-503
Manohar, Nivedh; Reynoso, Francisco J; Diagaradjane, Parmeswaran et al. (2016) Quantitative imaging of gold nanoparticle distribution in a tumor-bearing mouse using benchtop x-ray fluorescence computed tomography. Sci Rep 6:22079
Belousova, Natalya; Mikheeva, Galina; Xiong, Chiyi et al. (2016) Native and engineered tropism of vectors derived from a rare species D adenovirus serotype 43. Oncotarget 7:53414-53429
Melo, Sonia A; Luecke, Linda B; Kahlert, Christoph et al. (2015) Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523:177-82
Ramirez, Marc S; Lee, Jaehyuk; Walker, Christopher M et al. (2014) Radial spectroscopic MRI of hyperpolarized [1-(13) C] pyruvate at 7 tesla. Magn Reson Med 72:986-95
Ramirez, Marc S; Lai, Stephen Y; Bankson, James A (2013) A throughput-optimized array system for multiple-mouse MRI. NMR Biomed 26:237-47
Spivak-Kroizman, Taly R; Hostetter, Galen; Posner, Richard et al. (2013) Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer. Cancer Res 73:3235-47
Chintalgattu, Vishnu; Rees, Meredith L; Culver, James C et al. (2013) Coronary microvascular pericytes are the cellular target of sunitinib malate-induced cardiotoxicity. Sci Transl Med 5:187ra69
Sandulache, Vlad C; Skinner, Heath D; Wang, Yuan et al. (2012) Glycolytic inhibition alters anaplastic thyroid carcinoma tumor metabolism and improves response to conventional chemotherapy and radiation. Mol Cancer Ther 11:1373-80

Showing the most recent 10 out of 29 publications